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Allergic asthma is a chronic Th2 inflammatory disease of the lower airways affecting a 
growing number of people worldwide. The impact of infections and microbiota com-
position on allergic asthma has been investigated frequently. Until now, however, there 
have been few attempts to investigate the impact of asthma on the control of infectious 
microorganisms and the underlying mechanisms. In this work, we characterize the con-
sequences of allergic asthma on intranasal (i.n.) infection by Brucella bacteria in mice. We 
observed that i.n. sensitization with extracts of the house dust mite Dermatophagoides 
farinae or the mold Alternaria alternata (Alt) significantly increased the number of Brucella 
melitensis, Brucella suis, and Brucella abortus in the lungs of infected mice. Microscopic 
analysis showed dense aggregates of infected cells composed mainly of alveolar mac-
rophages (CD11c+ F4/80+ MHCII+) surrounded by neutrophils (Ly-6G+). Asthma-induced 
Brucella susceptibility appears to be dependent on CD4+ T cells, the IL-4/STAT6 signaling 
pathway and IL-10, and is maintained in IL-12- and IFN-γR-deficient mice. The effects 
of the Alt sensitization protocol were also tested on Streptococcus pneumoniae and 
Mycobacterium tuberculosis pulmonary infections. Surprisingly, we observed that Alt 
sensitization strongly increases the survival of S. pneumoniae infected mice by a T cell 
and STAT6 independent signaling pathway. In contrast, the course of M. tuberculosis 
infection is not affected in the lungs of sensitized mice. Our work demonstrates that the 
impact of the same allergic sensitization protocol can be neutral, negative, or positive with 
regard to the resistance of mice to bacterial infection, depending on the bacterial species.
Keywords: allergic asthma, infection, Brucella melitensis, Streptococcus pneumoniae, brucellosis, Mycobacterium 
tuberculosis 
inTrODUcTiOn
One striking feature of infectious diseases is the marked interindividual variation in susceptibility/
resistance. Interestingly, individuals with the highest level of infection are also often the major dis-
seminators (termed super-spreaders) of an epidemic among a population (1). Thus, with a better 
understanding of the factors predisposing individuals to susceptibility to a particular infectious 
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agent, we may be able to both anticipate and better treat indi-
vidual infections and more efficiently control the dissemination 
of infection among populations.
Allergic asthma is one of the most common lung diseases. 
It affects an estimated 300 million people worldwide (2) and its 
prevalence continues to increase in many parts of the world (3). 
It is characterized by recurring symptoms of reversible airflow 
obstruction, bronchial hyperresponsiveness and lower airway 
inflammation. The lungs of atopic individuals display increased 
levels of IL-4-mediated (Th2) inflammation and eosinophilia 
(4). The impact of infections and host microbiota composition 
on allergic asthma has been investigated frequently [reviewed in 
Ref. (5)]. However, despite the significant proportion of people 
worldwide affected by asthma and though some epidemiological 
studies (6–8) report increasingly severe bacterial and viral infec-
tions in asthma patients, little effort has been made to investigate 
the impact of asthma on the control of infectious microorganisms 
and identify the underlying mechanisms.
Brucella (alpha-proteobacteria) are facultative intracellular 
Gram-negative coccobacilli that infect wild and domestic mam-
mals and cause brucellosis. Human brucellosis is a zoonotic 
infection transmitted mainly through ingestion and inhalation 
(9). Airborne transmission is a major cause of outbreaks of 
human brucellosis in bovine and porcine slaughterhouses, vac-
cine production laboratories, research laboratories, and rural 
areas (10–13). Due to its easy aerosolization, high infectivity, 
and airborne transmission, Brucella species are considered 
potential biological weapons (14, 15) and are classified as cat-
egory B bioterrorism agents. Four species of Brucella can cause 
human disease: Brucella melitensis, Brucella abortus, Brucella 
suis, and Brucella canis. The vast majority of cases worldwide 
are attributed to B. melitensis [reviewed in Ref. (16)]. Although 
it is rarely fatal, Brucella can cause a devastating multi-organ 
disease in humans with serious health complications in the 
absence of prolonged antibiotic treatment (16, 17). Despite 
significant progress, the incidence of human brucellosis remains 
very high in endemic areas (18) and is considered to be largely 
underestimated (19, 20). Currently, there are no effective vac-
cines available to protect humans. All commercially available 
animal vaccines are live vaccines that would cause disease in 
humans (21, 22). In a mouse intranasal (i.n.) infection model, 
we demonstrated previously that IFN-γ-producing CD4+ T cells 
(Th1) are key actors in the control of Brucella multiplication and 
persistence in lungs (23).
In the current study, we developed an original experimental 
model to analyze the impact of allergic asthma sensitization on 
the course of i.n. Brucella infection in mice. Extracts of the house 
dust mite Dermatophagoides farinae (HDM) (24) and the mold 
Alternaria alternata (Alt) (25), which are both recognized as 
important causes of respiratory allergies, were used to sensitize 
mice before and during infection. Our results showed that allergic 
asthma increases the susceptibility of mice to Brucella infection. 
However, this phenomenon cannot be generalized to other 
bacterial infections as we observed that the same protocol led to 
better control of Streptococcus pneumoniae and had no effect on 




The procedures used in this study and the handling of the mice 
complied with current European legislation (directive 86/609/
EEC) and the corresponding Belgian law “Arrêté royal relatif à 
la protection des animaux d’expérience du 6 avril 2010 publié le 
14 mai 2010.” The Animal Welfare Committee of the Université 
de Namur (UNamur, Belgium) reviewed and approved the com-
plete protocol for Brucella infections (Permit Number: UN-LE-
14/220). The Animal Welfare Committee of the Université 
Libre de Bruxelles (ULB, Belgium) reviewed and approved the 
complete protocol for S. pneumoniae infections (Permit Number: 
ULB-IBMM-2016-21-88). The Ethics committee of the WIV-
ISP and CODA-CERVA approved the complete protocol for M. 
tuberculosis infections (ethics agreement number 201405-14-01).
Mice and reagents
Wild-type BALB/c and C57BL/6 mice were acquired from Harlan 
(Bicester, UK). STAT6−/− BALB/c mice, IL4−/− BALB/c mice, 
IL12p40−/− BALB/c mice, TCR-δ−/− C57BL/6 and IL-10GFP 
transgenic [B6(Cg)-Il10tm1.1Karp/J] C57BL/6 mice were all 
purchased from The Jackson Laboratory (Bar Harbor, ME, 
USA). IFN-γR−/− (26) and IL-12p35−/− C57BL/6 mice (27) were 
acquired from Dr. B. Ryffel (University of Orleans, France). 
TAP1−/− C57BL/6 mice (28), MHCII−/− C57BL/6 mice (29) 
were acquired from Jörg Reimann (University of Ulm, Ulm, 
Germany). IL-10−/− BALB/c mice were obtained from Guillaume 
Holdenhove (Université Libre de Bruxelles, Gosselies, Belgium). 
All wild-type and deficient mice used in this study were bred 
in the animal facility of the Gosselies campus of the Université 
Libre de Bruxelles (ULB, Belgium). We used wild-type strains of 
B. melitensis 16M and B. suis 1330. We also used B. melitensis 
16M and B. abortus 2308 strains stably expressing a rapidly 
maturing variant of the red fluorescent protein DsRed (30), the 
mCherry protein (mCherry-Br), under the control of the strong 
Brucella spp. promoter, PsojA. Construction of the mCherry-Br 
strains has been described previously in detail (31). All Brucella 
were handled under BSL-3 containment according to Council 
Directive 98/81/EC of 26 October 1998 and a law of the Walloon 
government of 4 July 2002.
Cultures were grown overnight with shaking at 37°C in 
2YT medium (Luria-Bertani brothwith double quantity of 
yeast extract) and were washed twice in RPMI 1640 (Gibco 
Laboratories) (3,500 × g, 10 min) before inoculation of the mice.
allergens and allergic asthma 
sensitization Protocol
Lyophilized house dust mite D. farinae (abbreviated HDM) 
extracts were from Greer Laboratories (Lenoir, NC, USA). 
A. alternata (strain18586) (abbreviated Alt) was obtained from the 
BCCM™/IHEM (Institute of Public Health, WIV-ISP, Brussels, 
Belgium) and cultured for 3 weeks at 27°C in flasks containing 
250  ml of Czapek medium. Mold pellicles were harvested and 
homogenized in 0.4% NH4HCO3  +  polyvinyl polypyrrolidone 
(Sigma) with an ultra-thurax. The homogenates were then 
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shaken for 3 h at 4°C. Extracts were centrifuged twice for 30 min 
at 20,000 g, dialyzed against phosphate-buffered saline (PBS) and 
stored at −20°C in 50% glycerol.
For asthma sensitization, mice were lightly anesthetized with 
isoflurane [from Abbott laboratories (# No. B506)]. Once the 
mice were unresponsive but breathing comfortably, a solution of 
HDM (100 µg of D. farinae extract in 50 µl of PBS) or Alt (5 µg 
of A. alternata extract in 100 µl of PBS) was applied directly to 
the nostrils. The animals were allowed to slowly inhale the liquid 
and were then allowed to recover in a supine position. For the 
HDM model, mice were instilled intranasally (i.n.) once per 
week throughout the experiment (32) and for the Alt model mice 
received the extract twice per week throughout the experiment 
(25). Mice were infected 17 days after the first instillation.
Brucella infection
Mice were anesthetized with a cocktail of Xylasine (9 mg/kg) and 
Ketamine (36  mg/kg) in PBS before being inoculated i.n. with 
2 × 103 or 2 × 104 CFU of B. melitensis, as indicated, 2 × 103 CFU 
of B. abortus, or 2 × 103 CFU of B. suis. We used wild-type or 
mCherry-expressing Brucella in 30 µl of PBS [described in Ref. 
(31)]. Control animals were inoculated with the same volume of 
PBS. The infectious doses were validated by plating serial dilu-
tions of the inoculums. At the selected time after infection, mice 
were sacrificed by cervical dislocation. Immediately after sacri-
fice, spleen, liver, and lung cells were collected for bacterial count, 
flow cytometry, and/or microscopic analyses. All infections were 
performed in an Animal Biosafety Level 3 facility.
For bacterial counting, organs were crushed and transferred to 
PBS/0.1% X-100 Triton (Sigma-Aldrich). We performed succes-
sive serial dilutions in RPMI to obtain the most accurate bacterial 
count and plated them on 2YT medium. The CFU were counted 
after 5 days of culture at 37°C.
S. pneumoniae infection
Streptococcus pneumoniae serotype 1 (clinical isolate E1586) were 
grown in Todd Hewitt Yeast Broth (Sigma-Aldrich) as described 
previously (33). For infection, frozen working stocks were washed 
and diluted in PBS. Mice were anesthetized by intraperitoneal 
injection of ketamine–xylazine and 20 µl of the lethal inoculum 
(2 × 107 CFU) were administered by i.n. route. Mouse survival 
was recorded every 24 h.
M. tuberculosis infection
BALB/c mice were infected with 50–100  CFU of virulent 
M. tuberculosis H37Rv using a nose-only inhalation exposure 
system (CH Technologies, Inc. Westwood, NJ, USA). The 
M. tuberculosis H37Rv strain used was grown for 2  weeks 
as a surface pellicle on Sauton medium and stored frozen in 
aliquots at −80°C. For bacterial counting, serial threefold total 
lung homogenate dilutions were plated on 7H11 Middlebrook 
agar supplemented with oleic acid-albumin-dextrose-catalase. 
Colonies were counted visually after 4  weeks. CFU counts 
obtained from two or three dilutions were used to calculate the 
total number of CFU/lung/mouse. Data are expressed as log10 
CFU per organ per mouse. All M. tuberculosis infections were 
performed in a BSL3 facility at the Scientific Institute of Public 
Health (WIV-ISP) according to rules established by the ethics 
committee of the WIV-ISP and CODA-CERVA (ethics agree-
ment number 201405-14-01).
Bronchoalveolar lavages (Bals)
Mice were euthanized by cervical dislocation. The trachea was 
exposed and incised. A needle (1.2 mm × 40 mm) was inserted 
into the trachea and bronchoalveolar fluid was harvested by 
washing the lungs twice with 1 ml of PBS. Total cell counts were 
determined with a hemacytometer. Differential cell counts were 
obtained by counting at least 500 cells on cytospin slides stained 
with Diff-Quick (Dade Behring).
Determination of serum levels  
of Total ige
Serum IgE levels in sera were determined using a sandwich 
ELISA. Plates were coated with a rat antimouse IgE mAb (LO-
ME-2, IMEX, UCL, Brussels, Belgium) and saturated. Serial 
twofold dilutions of serum or purified monoclonal mouse IgE 
(LB-4, IMEX, UCL, Brussels, Belgium) were applied for 2  h. 
Then, peroxidase labeled rat antimouse IgE (LO-ME-3) was 
used. After 1 h of incubation at room temperature (RT), plates 
were washed four times in PBS, and 100  µl substrate solution 
(BD OptEiA; BD Biosciences) was added to each well. After 
10 min of incubation at RT in the dark, the enzyme reaction was 
stopped by adding 25 μl/well 2 N H2SO4, and absorbance was 
measured at 450 nm.
Quantitative Pcr for il-4
Total RNA was extracted from homogenized lung cells with 
Tri-reagent (Sigma-Aldrich), according to the manufacturer’s 
instructions 24  h after the last instillation. cDNA was synthe-
sized using the Promega GoScript Reverse Transcription System. 
RT-qPCR was performed on a Stratagene Mx 3000P using a 
qPCR Go Taq master mix with Bryt Green (Promega). Each 
RT-qPCR amplification was performed in duplicate under the 
following conditions: 95°C for 10 min, followed by 40 cycles at 
95°C for 15 s and 60°C for 1 min. The forward and reverse primers 
used for IL-4 were 5-GTGCAGCTTATCGATGAATCC-3′ and 
5-AGCCATATCCACGGATGCGAC-3, Hydroxymethylbilane syn-
thase (HmBS, forward 5′-GAAACTCTGCTTCGCTGCATT-3′, 
reverse 5′-TGCCCATCTTTCATCACTGTATG-3′) mRNA was 
used as the reference housekeeping gene for normalization. For 
each sample (x), the normalization factor was calculated using the 
formula, mean of Ct of ref(i) − Ct of ref(x), where i represents all 
samples (Ct is on the threshold cycle-value shown as the mean 
of three different RT-qPCR reactions), as described in Ref. (34). 
The level of target mRNA, relative to the mean of the reference 
housekeeping gene, was calculated by raising 2 to the power of 
{40 − [Ct of target + mean of (Ct of norm. HmBS)]}.
Determination of arginase activity
Arginase activity was determined by measuring the total pro-
duction of urea from lung homogenates. Individual lungs were 
crushed and transferred to 1 ml of PBS. The homogenates were 
centrifuged, and urea levels were determined in the supernatant 
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using an Arginase Activity Assay kit (Sigma MAK112). Arginase 
activity is expressed as units per liter of sample, where 1 unit of 
arginase converts 1 μmole of l-arginine to ornithine and urea per 
min at pH 9.5 and 37°C.
arginase inhibition
Mice were injected i.n. with 200 µg of nor-NOHA (N-hydroxy-
nor-l-arginine, Enzolifesciences) in 50 µl of PBS on days 8, 15, 18, 
21, 24, and 27 post first mold instillation. In order to verify the 
effectiveness of the inhibitor, we measured the arginase activity 
using the Arginase Activity Assay kit (Sigma MAK112) on naive 
and asthmatic lung extracts in the presence or absence of nor-
NOHA (2 mg/ml) during the arginase reaction.
cytofluorometric analysis
As described previously (23), lungs were harvested, cut 
into small pieces, and incubated for 1  h at 37°C with a mix 
of DNAse I fraction IX (Sigma-Aldrich) (100  µg/ml) and 
1.6 mg/ml of collagenase (400 Mandl U/ml). Lung cells were 
washed and filtered, and then incubated with saturating doses 
of purified 2.4G2 (anti-mouse Fc receptor, ATCC) in 200  µl 
PBS, 0.2% BSA, 0.02% NaN3 (FACS buffer) for 20 min at 4°C 
to prevent antibody (Ab) binding to the Fc receptor. Various 
fluorescent mAb combinations in FACS buffer were used to 
stain 3–5 × 106 cells. We acquired the following mAbs from BD 
Biosciences: Fluorescein (FITC)-coupled HL3 (anti-CD11c), 
FITC-coupled 145-2C11 (anti-CD3ε), FITC-coupled M1/70 
(anti-CD11b), FITC-coupled 1A8 (anti-Ly6G), phycoerythrin 
(PE)-coupled RM4-5 (anti-CD4), PE-coupled 53-6.7 (anti-
CD8α), PE-coupled PK136 (anti-NK1.1), PE-coupled GL3 
(anti–TCR-γ/δ), PE-coupled E50-2440 (anti-SIGLEC-F), allo-
phycocyanin (APC)-coupled BM8 (anti-F4/80), biotin-coupled 
M5/114.15.2 (anti-MHCII, I-A/I-E), and biotin-coupled 
307707 (anti-CD101). Incubation with a streptavidin-coupled 
APC for 30 min was necessary for the biotin-coupled Ab. The 
cells were analyzed on a FACScalibur cytofluorometer. Dead 
cells and debris were eliminated from the analysis according to 
size and scatter.
immunofluorescence Microscopy
Lungs were fixed for 2  h at RT in 2% paraformaldehyde (pH 
7.4), washed in PBS, and incubated overnight at RT in a 20% 
PBS-sucrose solution under a vacuum. Tissues were then 
embedded in the Tissue-Tek OCT compound (Sakura), frozen in 
liquid nitrogen, and cryostat sections (5 µm) were prepared. For 
staining, tissue sections were rehydrated in PBS and incubated 
in a PBS solution containing 1% blocking reagent (Boeringer) 
(PBS-BR 1%) for 20 min before incubation overnight in PBS-BR 
1% containing any of the following mAbs or reagents: DAPI 
nucleic acid stain Alexa Fluor 350, 488 phalloidin (Molecular 
Probes), biotin-coupled 1A8 (anti-Ly6G), biotin-coupled 
53-2.1 (anti-CD90.2), biotin-coupled polyclonal anti mouse 
Major Binding Protein (MBP, MyBioSource), Alexa Fluor® 
647-coupled M5/114.15.2 (anti-I-A/I-E, MHCII), APC-coupled 
BM8 (anti-F4/80, Abcam), Alexa Fluor 647-coupled HL3 
(anti-CD11c, BD Biosciences). Incubation with a streptavidin-
coupled APC for 2 h was necessary for the biotin-coupled Ab. 
iNOS and arginase-1 were detected using IgG H-52 (anti-Arg1, 
Santa Cruz Biotechnology) and rabbit polyclonal anti-NOS2 Ab 
(Calbiochem), respectively and were stained with a secondary 
Ab, Alexa Fluor 647-coupled goat anti-rabbit IgG (Molecular 
Probes). Slides were mounted in Fluoro-Gel medium (Electron 
Microscopy Sciences, Hatfield, PA, USA). Labeled tissue sections 
were visualized with an Axiovert M200 inverted microscope 
(Zeiss, Iena, Germany) equipped with a high-resolution mono-
chrome camera (AxioCam HR, Zeiss). Images (1,384  ×  1,036 
pixels, 0.16 μm/pixel) were acquired sequentially for each fluo-
rochrome with A-Plan 10×/0.25  N.A. and LD-Plan-NeoFluar 
63×/0.75 N.A. dry objectives and recorded as eight-bit gray-level 
*.zvi files. At least three slides were analyzed per organ from 
three different animals and the results are representative of two 
independent experiments.
confocal Microscopy
Confocal analyses were performed using the LSM780 confocal 
system fitted on an Observer Z 1 inverted microscope equipped 
with an alpha Plan Apochromat 63×/1.46 NA oil immersion 
objective (Zeiss, Iena, Germany). Hoechst/DAPI was excited 
using a 405 nm blue diode, and emission was detected using 
a band-pass filter (410–480 nm). The 488 nm excitation wave-
length of the Argon/2 laser was used in combination with a 
band-pass emission filter (BP500–535  nm) to detect Alexa 
Fluor 488 phalloidin. The 543 nm excitation wavelength of the 
HeNe1 laser, and a band-pass emission filter (BP580–640 nm) 
were used for the red fluorochrome mCherry. The 633 excita-
tion wavelength of the HeNe2 laser, and a band-pass emission 
filter (BP660–695  nm) were used for far-red fluorochromes 
such as APC. To ensure optimal separation of the fluoro-
chromes, blue and red signals were acquired simultaneously 
in one track and green and far-red signals were acquired in a 
second track. The electronic zoom factor and stack depth were 
adjusted to the region of interest while keeping image scaling 
constant (x–y: 0.066 µm, z: 0.287 µm). A line average of 4 was 
used and datasets were stored as 8-bit proprietary *.czi files. 
The images were displayed using Zen2012 software (Zeiss) 
with linear manual contrast adjustment and exported as 8-bit 
uncompressed *.TIF images. The Figures, representing single 
optical sections across the region of interest, were prepared 
using the Canvas program.
hematoxylin-eosin-safran (hes) histology
Lungs were fixed in 10% formalin. After fixation overnight, the 
lungs were embedded in paraffin. Tissues were sliced and 5 µm 
sections were stained with HES for light microscopy examination 
of the lung inflammation.
statistical analysis
We used a (Wilcoxon-)Mann–Whitney test provided by the 
GraphPad Prism software to statistically analyze our results. 
Each group of deficient mice was compared to the wild-type 
mice. We also compared each group with the others and displayed 
the results when required. Values of p  <  0.05 were considered 
to represent a significant difference. *, **, *** denote p <  0.05, 
p < 0.01, p < 0.001, respectively.
FigUre 1 | Impact of allergic asthma sensitization on the course of Brucella infection in wild-type mice. Wild-type BALB/c and C57BL/6 mice received repeated i.n. 
administration of phosphate-buffered saline, HDM, or Alt before i.n. infection with 2 × 104 CFU of mCherry-Brucella melitensis (a,B) or 2 × 103 CFU of B. melitensis, 
B. abortus, or Brucella suis (c), as indicated in the figure and in the Section “Materials and Methods.” The mice were sacrificed at the selected time post infection. 
The data represent the number of CFU/gr of lung, spleen, and liver. n denotes the number of mice used for each lineage. These results are representative of at least 
two independent experiments. **p < 0.01, ***p < 0.001.
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resUlTs
allergic asthma Favors the Multiplication 
of Brucella in the lungs
Repeated intranasal (i.n.) sensitization with an extract from 
the house dust mite D. farinae (HDM) (24) or an extract of 
the mold A. alternata (Alt) (25) has been described to induce 
allergic asthma in murine models. Under our experimental 
conditions, BALB/c mice sensitized during 17 days according 
to standard protocols (see Materials and Methods) display 
readily detectable cellular infiltration in the lungs (Figure 
S1A in Supplementary Material). BALs showed an increased 
FigUre 2 | Microscopic analysis of lungs from control, HDM and Alt sensitized BALB/c mice. Wild-type BALB/c mice received repeated i.n. administration of 
phosphate-buffered saline (PBS) or Alt before i.n. inoculation of PBS or 2 × 104 CFU of mCherry-Brucella melitensis. The mice were sacrificed at 12 days post 
infection. The lungs were harvested and fixed. Frozen sections were examined by immunohistofluorescence for bacteria (mCherry signal) and Ly-6G-expressing 
cells. (a) Comparison of control (cont), HDM, and Alt sensitized mice, infected or not. (B) High magnification representative view from Alt sensitized infected mice.  
The panels are color-coded by Ag as indicated. The data are representative of two independent experiments.
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FigUre 3 | Cell surface phenotype of Brucella melitensis infected cells in asthmatic lungs. Wild-type BALB/c mice received repeated i.n. administration of Alt before 
i.n. infection with 2 × 104 CFU of mCherry-B. melitensis. The mice were sacrificed at 12 days post infection. The lungs were harvested and fixed. Frozen sections 
were examined by immunohistofluorescence for mCherry (Brucella), CD11c, F4/80, MHCII, major basic protein (MBP), Ly-6G, and CD90 signals. The panels are 
color-coded by antigen as indicated. (a) High magnification representative view of infected cells in the lungs. (B) The data represent the percentage of mCherry-Br 
signal that co-localizes with CD11c, F4/80, MHCII, MBP, Ly-6G, and CD90 markers. When >12 infected cells are observed in the same observation field 
(approximately 700 μm × 500 μm), they are considered as “aggregated,” and when <12 are observed, they are considered as “isolated.” At least 200 infected cells 
from three different infected mice were analyzed for each staining. These data are taken from two independent experiments.
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number of lymphocytes, macrophages, neutrophils, and 
eosinophils (Figure S1B in Supplementary Material). As 
expected, this phenomenon was associated with increased IL-4 
mRNA expression in the lungs (Figure S1C in Supplementary 
Material) and increased total IgE in the blood (Figure S1D 
in Supplementary Material). Alt induced stronger cellular 
recruitment in the lungs, but closely similar IL-4 and IgE levels 
compared to HDM.
FigUre 4 | Alveolar macrophages and neutrophils are both infected with Brucella melitensis in the lungs of Alt-sensitized BALB/c mice. Wild-type BALB/c mice 
received repeated i.n. administration of Alt before i.n. infection with 2 × 104 CFU of mCherry-B. melitensis. The mice were sacrificed at 12 days post infection. The 
lungs were harvested, fixed, and frozen sections were immunostained and examined by confocal microscopy. (a,B) Representative confocal images of single optical 
sections of mCherry-Br infected CD11c+ cells and Ly-6G+ cells stained with DAPI from Alt sensitized wild-type BALB/c mice. (c) Representative infected 
multinucleated giant cells stained with DAPI and phalloidin. The panels are color-coded for DAPI, phalloidin, the cell surface antigen examined or mCherry-Brucella. 
Scale bars = 10 µm, as indicated.
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IFN-γ producing CD4+ T (Th1) cells play a key role in the 
control of B. melitensis infection (23). As chronic IL-4-dominated 
Th2 response induced by helminthes is well known to negatively 
affect the Th1 response (35–41), we compared the ability of 
groups of mice subjected to i.n. sensitization with PBS (cont), 
HDM, or Alt for 17 days to control i.n. B. melitensis infection. 
We chose a dose of Brucella infection similar to that used in our 
previous characterization of the B. melitensis intranasal infection 
model (23): 2 × 104 CFU, as described in the Section “Materials 
and Methods.” This was a compromise to limit the individual 
variability resulting from the use of a low dose of infection 
(102–103 CFU) and the pulmonary inflammation resulting from 
a high dose of infection (106–107 CFU). It is important to note 
that the sensitization treatments were continued throughout the 
course of infection in all of our experiments to mimic chronic 
asthma. We observed that HDM and Alt sensitization negatively 
affect the control of B. melitensis infection in the lungs but have a 
weak or no effect in the spleen and liver (Figure 1A). Asthmatic 
mice display strongly enhanced bacterial loads in the lungs, with 
mean bacteria CFU/gr that were 416 times higher in the HDM 
group and 26,302 times higher in the Alt group compared to the 
control group at 12 days post infection.
Genetic background is important to the Th1/Th2 balance in 
mice. C57BL/6 mice preferentially mount a Th1 response with 
high IFN-γ and low IL-4, whereas that in BALB/c mice is a Th2 
response with low IFN-γ and high IL-4 in vitro (42) and in vivo 
(43). Thus, C57BL/6 is regarded as a prototypic Th1-biased 
mouse strain. Despite this Th1 bias, C57BL/6 mice sensitized 
with HDM or Alt also display enhanced bacterial growth in 
the lungs (Figure 1B), demonstrating that this phenomenon is 
not restricted to Th2-biased BALB/c mice. Finally, to generalize 
our observation, we also tested the impact of Alt sensitization 
on the ability of BALB/c mice to control B. suis and B. abortus 
infection, the two other classical Brucella species causing human 
brucellosis. At 12 days post infection, we observed that asthmatic 
mice display enhanced levels of both Brucella strain in the lungs 
(Figure 1C). Note that we used a lower dose (2 × 103 CFU) of B. 
melitensis, B. suis, and B. abortus to infect the mice, because B. 
suis and B. abortus already display a higher level of growth and 
persistence in the lungs of control mice compared to B. melitensis.
Using mCherry-expressing B. melitensis (31), we performed 
a microscopic fluorescent analysis to identify infected cells in 
lung tissues from control HDM- and Alt-sensitized BALB/c 
mice. Infected lungs from asthmatic mice display large and dense 
aggregates of Ly-6G+ cells, presumably neutrophils, surrounding 
highly infected cells (Figures  2A,B). These aggregates are not 
observed in the other groups of mice. Due to a low CFU level, 
infected cells could not be detected in the control mice.
In asthmatic mice, mCherry+ infected cells are heterogeneous 
in phenotype and morphology (Figure  3A). A large fraction 
of the mCherry signal colocalizes with CD11c, F4/80, MHCII, 
and Ly-6G markers but rarely with major basic protein (MBP) 
or CD90 (Figure  3B), suggesting that infected cells are pre-
dominantly composed of alveolar macrophages (CD11c+ F4/80+ 
FigUre 5 | Impact of IL-4 and STAT6 deficiency on asthma-induced Brucella susceptibility in BALB/c mice. Wild-type, IL4−/− and STAT6−/− BALB/c mice received 
repeated i.n. administration of phosphate-buffered saline, HDM, or Alt before i.n. infection with 2 × 104 CFU of mCherry-Brucella melitensis. The mice were 
sacrificed at 12 days post infection. The data represent the number of CFU/gr of lung at 12 days post infection from each group. n denotes the number of mice  
used for each lineage. These results are representative of at least two independent experiments. ***p < 0.001.
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MHCII+) and neutrophils (Ly-6G+), but not of eosinophils 
(MBP+) or T cells (CD90+). The more highly infected cells are 
large cells with a typical alveolar macrophage morphology and 
colocalizing with the CD11c, F4/80, and MHCII staining. In 
contrast, the infected cells are small cells displaying fewer bac-
teria and are mainly observed in dense aggregates surrounding 
highly infected alveolar macrophages (Figure 2B). Infection of 
the Ly-6G+ neutrophils (Figure 4A) and CD11c+ alveolar mac-
rophages (Figure  4B) was confirmed by confocal microscopy. 
We also observed the presence of highly infected multinucleated 
giant cells in the infected asthmatic mice (Figure 4C). These cells 
express low levels of CD11c, suggesting that they could result 
from the fusion of infected alveolar macrophages.
allergic asthma-induced susceptibility to 
Brucella is Dependent on the il-4/sTaT6 
signaling Pathway and cD4+ T cells
Mice deficient for IL-4, IL-13, or STAT6 develop attenuation 
of certain features of asthma, including eosinophil recruit-
ment and airway hyperresponsiveness (44, 45). However, DNA 
microarray profile analysis of wild-type and STAT6−/− asthmatic 
mice showed that a large portion of the transcriptional asthma 
signature is STAT6 independent (46). Comparative analysis of 
wild-type and STAT6−/− asthmatic lungs showed that sensitized 
STAT6−/− mice displayed reduced IgE levels in the blood (Figure 
S2A in Supplementary Material) and reduced infiltration of 
lymphocytes and eosinophils in the lung airways (Figure S2B in 
Supplementary Material). In contrast, macrophage and neutro-
phil infiltration remains much higher in sensitized STAT6−/− mice 
than in control STAT6−/− mice. As neutrophils have been reported 
to exert a suppressive effect on the protective response against 
Brucella (47), we thought first to determine whether enhanced 
susceptibility to B. melitensis lung infection induced by HDM 
and Alt treatment is dependent or independent of the IL-4/
STAT6 signaling pathway. We, therefore, compared the impact of 
HDM and Alt sensitization on B. melitensis infection in wild-type, 
IL-4−/− and STAT6−/− BALB/c mice. We observed that neutraliza-
tion of the IL-4/STAT6 signaling pathway completely abrogates 
the enhanced susceptibility to B. melitensis infection due to both 
HDM and Alt sensitization (Figure 5), thus demonstrating that 
enhanced susceptibility to Brucella observed in asthmatic wild-
type mice is strictly dependent on the Th2 response. Note that 
we have previously published (48) that the absence of STAT-6 
signaling does not affect the course of B. melitensis infection in 
non-asthmatic BALB/c mice.
FigUre 6 | Impact of T lymphocyte deficiency on Alt-induced Brucella 
susceptibility. Wild-type, γδTCR−/−, TAP1−/−, and MHCII−/− C57BL/6 mice 
received repeated i.n. administration of phosphate-buffered saline or Alt 
before i.n. infection with 2 × 104 CFU of mCherry-Brucella melitensis.  
The mice were sacrificed at 12 days post infection. (a) The data represent 
the number of eosinophils recruited (SIGLEC-F+ CD11c− CD101+) × 105 per 
lung from each group as determined by flow cytometry. (B) The data 
represent the number of CFU/gr of lung at 12 days post infection from each 
group. Horizontal gray lines represent the medians. n denotes the number  
of mice used for each lineage. These results are representative of at least 
three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001.
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As both αβ+CD4+ T cells (4) and γδ+ T cells (49) have been 
implicated in the development of allergic asthma in mice models, 
we next compared the ability of wild-type, γδ−/−, TAP1−/− (CD8+ 
T cells deficient), and MHCII−/− (CD4+ T cells deficient) C57BL/6 
mice sensitized with Alt to control i.n. B. melitensis infection. 
Flow cytometry analysis (Figure 6A) showed that CD4+ T cell 
deficiency completely abrogated inflammatory eosinophil 
recruitment [SIGLEC-F+ CD11c− CD101+ cells (50)] in infected 
asthmatic mice. The absence of γδ+ T  cells and CD8+ T  cells 
also significantly reduces eosinophil recruitment, though more 
moderately. However, we observed that only CD4+ T  cell defi-
ciency impaired Alt-induced susceptibility to Brucella infection 
significantly (Figure 6B).
allergic asthma-induced susceptibility  
to Brucella is not associated With 
Preferential Multiplication in M2 
Macrophages and is independent  
of arginase-1 activity
Allergic asthma is associated with increased polarization of alveo-
lar macrophages toward an M2 phenotype characterized by high 
arginase-1 expression levels [reviewed in Ref. (51)]. It has been 
demonstrated that, in vitro, B. abortus multiply more actively in 
arginase-1+ M2 macrophages than in iNOS+ M1 macrophages 
(52), and we have reported that B. melitensis splenic reservoir 
cells from infected IL-12−/− mice express high levels of arginase-1 
(48). Thus, we tried to determine whether asthma-induced 
susceptibility to Brucella infection could be the consequence 
of the preferential invasion by Brucella of more abundant M2 
macrophages present in asthmatic lungs. As expected, Alt sen-
sitization significantly increases arginase activity in the lungs 
(Figure  7A) and microscopic analysis showed that infected 
asthmatic mice display an increase number of arginase-1+ cells 
(Figure  7B). However, these mice also display much higher 
numbers of iNOS+ cells (Figure 7B) compared to infected control 
mice. Microscopic analysis showed that infected cells colocalize 
with arginase-1 and iNOS staining at an almost equivalent fre-
quency (Figure 7C), demonstrating that Brucella multiplication 
is no more associated with the M1 profile than with the M2 profile 
in our experimental model. We also observed that neutralization 
of arginase activity by repeated administration of nor-NOHA, a 
specific arginase inhibitor known to have the capacity to attenuate 
allergic airway inflammation (53) and neutralize arginase activity 
of asthmatic lungs in vitro (Figure S3 in Supplementary Material), 
does not reduce susceptibility to Brucella infection induced by 
Alt-sensitization (Figure 7D). On the whole, these data suggest 
that asthma-induced susceptibility to Brucella is not dependent 
on preferential invasion of M2 macrophages or arginase activity.
allergic asthma-induced susceptibility  
to Brucella is Partially Dependent  
on il-10 but independent of il-12
IL-10 is an anti-inflammatory cytokine notably produced by 
T cells (54) and B cells (55) during the asthma reaction. It is a 
master negative regulator of the Th1 response (56, 57) able to 
reduce the protective immune response against Brucella (58). 
We compared the ability of HDM and Alt sensitized wild-type, 
IL-10−/−, and IL-12p40−/− BALB/c mice to control B. melitensis 
infection. While IL-10 deficiency in BALB/c mice strongly 
reduces asthma-induced susceptibility (158- to 1.7-fold increase 
for HDM and 1,148- to 75-fold increase for Alt), this is not the 
case of IL-12p40 deficiency (158- to 1,324-fold increase for HDM 
and 1,148- to 74,131-fold increase for Alt) (Figure 8A). A similar 
result was observed in C57BL/6 mice, thus demonstrating that 
this result is not dependent on the mouse strain used. The absence 
of IL12p35 and IFN-γR in C57BL/6 mice does not reduce (204- to 
812-fold increase) or affects weakly (204- to 89-fold increase) the 
impact of asthma sensitization on Brucella levels, respectively 
(Figure 8B). Flow cytometry analysis of lung cells from control, 
FigUre 7 | Continued
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FigUre 7 | Asthma-induced Brucella susceptibility is independent of arginase activity. Wild-type BALB/c mice received repeated i.n. administration of phosphate-
buffered saline (PBS) (control) or Alt before i.n. administration of PBS or 2 × 104 CFU of mCherry-Brucella melitensis. The mice were sacrificed at 12 days post 
infection. The lungs were harvested and fixed. Frozen sections were examined by immunohistofluorescence for mCherry (Brucella), arginase-1 and iNOS signals. 
During the sensitization and infection process, the mice received repeated administration of PBS (control group) or the arginase inhibitor nor-NOHA. (a) The panel 
represents the arginase activity/lung homogenate from control and Alt sensitized wild-type BALB/c mice. (B) Representative view of mCherry+, arginase+, and iNOS+ 
cells in the lungs of control and Alt sensitized mice. The panels are color-coded by antigen as indicated. (c) The data represent the percentage of mCherry-Br signal 
that co-localizes with arginase-1 and iNOS staining. When >12 infected cells are observed in the same observation field (approximately 700 μm × 500 μm), they are 
considered as “aggregated,” and when <12 are observed, they are considered as “isolated.” At least 200 infected cells from three different infected mice were 
analyzed for each staining. (D) The panel represents the number of CFU/gr of lung at 12 days post infection from each group of mice. Horizontal gray lines represent 
the medians. n denotes the number of mice used for each lineage. These results are representative of at least two independent experiments. **p < 0.01, 
***p < 0.001.
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HDM, and Alt sensitized infected transgenic mice expressing GFP 
under the control of the IL-10 promoter (IL-10GFP mice) showed 
that IL-10 is mainly produced by B cells in control mice and by 
B  cells, CD4+ T  cells, and to a lesser extent eosinophils, CD8+ 
T and NK1.1+ cells following asthma sensitization (Figure  9). 
Unfortunately, alveolar macrophages display high levels of auto-
fluorescence in the GFP channel (59), thus rendering analysis 
of their IL-10 expression in IL-10GFP mice impossible. Taken 
together, these results suggest that IL-10 is a major mediator of 
HDM and Alt-induced susceptibility to B. melitensis lung infec-
tion, but that this phenomenon is independent of neutralization 
of the IL-12-dependent Th1 signaling pathway.
allergic asthma Does not affect 
Protective immune Memory against 
Brucella
As both HDM and Alt sensitization strongly favor the growth 
of B. melitensis in the lungs, we tried to determine whether they 
also affect the development of protective memory. We compared 
the ability of groups of wild-type and STAT-6−/− BALB/c mice 
sensitized with PBS, HDM, or Alt during the course of a primary 
i.n. Brucella infection to control a secondary i.n. infection. As 
described in Figure 10A, mice were sensitized for 17 days with PBS 
(control), HDM, or Alt. before receiving 2 × 104 CFU of wild-type 
B. melitensis i.n. Fifty days later, the mice were challenged with 
mCherry-expressing B. melitensis and sacrificed 28 days post chal-
lenge. Note that the sensitization treatment was continued during 
both primary infection and secondary infection in order to mimic 
chronic asthma inflammation. As illustrated in Figures 10B,C, we 
observed that all groups of wild-type and STAT-6−/− BALB/c mice, 
whether sensitized or not, displayed a similar ability to control 
secondary Brucella infection in the spleen or lungs, suggesting 
that chronic asthma does not significantly affect the development 
of protective memory against i.n. B. melitensis infection.
allergic asthma increases resistance  
to S. pneumoniae infection in Mice
As the Alt sensitization protocol strongly increases the suscep-
tibility of mice to pulmonary Brucella infection, we tried to 
determine whether this effect could be generalized to other lung 
infections with extracellular or intracellular bacteria. Therefore, 
we analyzed the impact of Alt sensitization on S. pneumoniae and 
M. tuberculosis infection in mice, two common serious human 
pulmonary pathogens.
Control and Alt sensitized wild-type C57BL/6 (Figures 11A,B) 
and BALB/c (Figure 11C) mice were infected i.n. with 2 × 107 CFU 
of S. pneumoniae. This bacterial dose is 95–100% lethal in control 
C57BL/6 and BALB/c mice, but appears to be well tolerated by 
asthmatic mice. Only 10–15% of the latter died after 10 days of 
infection. As expected, asthma-induced resistance is associated 
to a drastic reduction of CFU count in lung and spleen 48 h post 
infection (Figure 11B). Surprisingly, asthma-induced resistance 
to S. pneumoniae is also observed in sensitized CD3−/− C57BL/6 
mice (Figure 11A) and STAT-6−/− BALB/c mice (Figure 11C), 
demonstrating that the protective effect of asthma is independent 
of Th2 CD4+ T cells.
Control and Alt sensitized wild-type BALB/c mice (Figure 12) 
were also infected by aerosol with 100 CFU of M. tuberculosis. We 
observed that control and asthmatic mice display similar CFU 
counts in the lungs at 12 and 28 days post infection, suggesting 
that Alt sensitization does not significantly affect the course of M. 
tuberculosis infection in the lungs.
On the whole, these results demonstrate that the same asthma 
sensitization protocol can affect the ability of the immune system 
to control lung bacterial infections in very different and unpre-
dictable ways.
DiscUssiOn
Allergic asthma is one of the most common chronic inflamma-
tory lung diseases affecting humans (2, 3). The risk factors for 
developing asthma are a combination of genetic predisposition 
along with environmental exposure to inhaled substances. The 
most common indoor allergens are derived from dust mites, 
mammals (including wild rodents and pets), and fungi (60). 
Infection also plays a well-documented role in the development 
of asthma (5). Conversely, the impact of asthma as a predispos-
ing or aggravating condition to infection has been documented 
[for a review, see Ref. (61)] but has rarely been clearly addressed 
experimentally. Allergic asthma is dominated by the IL-4 (Th2) 
immune response that is well known since the pioneering work 
of Mossman and Coffman (35) to counter-regulate the IFN-γ 
dominated (Th1) immune response that controls viral and bacte-
rial infection. For example, the chronic Th2 response induced 
by helminth infections has been associated in numerous experi-
mental models with an impaired Th1 response to intracellular 
(36–38) and extracellular (39) bacteria as well as viruses (40, 
41) and can reduce the efficacy of vaccines (62–64). However, 
contradictory results have been also reported, showing no effect 
FigUre 8 | Impact of IL-10 and IL-12 deficiency on asthma-induced Brucella susceptibility. (a) Wild-type, IL-10−/−, and IL-12p40−/− BALB/c mice received repeated 
i.n. administration of phosphate-buffered saline (PBS) or Alt before i.n. infection with 2 × 104 CFU of mCherry-Brucella melitensis. The mice were sacrificed at 
12 days post infection. The data represent the CFUs per gram of lung. (B) Wild-type, IL-12p35−/−, and IFN-γR−/− C57BL/6 mice received repeated i.n. administration 
of PBS or Alt before i.n. infection with 2 × 104 CFU of mCherry-B. melitensis. The mice were sacrificed at 12 days post infection. The data represent the CFU/gr of 
lung. Horizontal gray lines represent the medians. n denotes the number of mice used for each lineage. These results are representative of at least three 
independent experiments. **p < 0.01, ***p < 0.001.
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FigUre 9 | Characterization of IL-10 producing cells in lungs from infected asthmatic mice. IL-10GFP transgenic C57BL/6 mice were sensitized with phosphate-
buffered saline (PBS) (control group), HDM, or Alt before i.n. infection with 2 × 104 CFU of Brucella melitensis. The mice were sacrificed at 12 days post infection, 
and the spleen cells were analyzed by flow cytometry. (a) Cells from PBS, HDM, and Alt infected mice were analyzed for IL-10GFP, CD3, and CD4 expression. The 
figure shows representative dot plots from individual lungs in each group, as indicated in the figure. Numbers represent the percentage of IL-10GFP+ cells in 50,000 
acquired events. (B) The data represent the number of IL-10GFP+ eosinophils, γδ+ T cells, B cells, CD4+ T cells, CD8+ T cells, and natural killer cells per 105 lung 
cells from control, HDM, and Alt infected mice. The data are representative of two independent experiments.
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(65) or even boosting effect (66) of helminth infections on the 
Th1 response.
In the present study, we analyzed the impact of chronic i.n. 
sensitization with house dust mite D. farinae (HDM) or mold 
A. alternata (Alt) extracts on the course of Brucella spp., S. 
pneumoniae, and M. tuberculosis lung infections. We observed 
that both asthma sensitization protocols strongly enhanced the 
growth of Brucella melitensis in the lungs, but not in other organs 
such as the spleen or liver following i.n. infection. In particular, at 
12 days post infection, Alt sensitization induced a 2 and 3 log CFU 
increase in the lungs of C57BL/6 and BALB/c mice, respectively. 
This increase is very surprising by comparison with the impact 
of IFNγ-R or αβTCR deficiency in C57BL/6 that only leads to 
a 1 to 1.5 log increase of Brucella in the lungs of C57BL/6 (23). 
The lungs of infected asthmatic mice display large aggregates 
of Ly-6G+ cells, presumably neutrophils, surrounding Brucella 
infected alveolar macrophages (CD11c+ F4/80+ cells). Infection is 
concentrated in these areas and large fractions of lung tissue seem 
FigUre 10 | Influence of allergic asthma on the development of protective 
memory against Brucella melitensis. Wild-type and STAT-6−/− BALB/c mice 
were sensitized with phosphate-buffered saline (PBS), HDM, or Alt extracts, 
as described in the Section “Materials and Methods,” throughout the entire 
experiment. Primary and secondary groups received i.n. administration of 
PBS or 2 × 104 CFU of wild-type B. melitensis at 17 days, respectively. All 
groups were infected i.n. with 2 × 104 CFU of mCherry-B. melitensis at 
67 days, were sacrificed at 95 days, and the spleens were harvested and  
the CFUs were counted. (a) Is a schematic representation of the protocol. 
(B,c) Represent the number of CFU/gr of lung (B) and spleen (c). Horizontal 
gray lines represent the medians. n denotes the number of mice used for 
each lineage. These results are representative of at least two independent 
experiments. ***p < 0.001.
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uninfected and healthy. In keeping with this observation, mortal-
ity was not increased in the infected asthmatic mice, even after 
100 days of chronic sensitization and infection (data not shown). 
Asthma sensitization also favors the growth of B. abortus and 
B. suis infection in the lungs, demonstrating that this phenomenon 
can be observed with the three main Brucella species described 
to infect humans.
Comparison of various mice strains displaying selective defi-
ciencies for key elements of the immune response demonstrated 
that the impact of asthma on Brucella lung infection is strictly 
dependent on CD4+ T  cells and IL-4/STAT6 pathways, which 
suggests that IL-4-producing Th2 CD4+ T cells are key actors of 
this phenomenon. IL-10 deficiency partially restores the control of 
Brucella multiplication in the lungs of asthmatic mice. Flow cytom-
etry analysis of IL-10GFP transgenic mice showed that asthma 
sensitization increases the frequency of IL-10-producing cells in 
the lungs. Taken together, these data suggest that asthma-induced 
susceptibility is partially due to the inhibition by IL-10 of immune 
effector mechanisms controlling Brucella multiplication in the 
lungs. However, asthma-induced susceptibility is also observed 
in IL-12−/− and IFN-γR−/− mice, suggesting that asthma-induced 
IL-10 affects IL-12 independent effector mechanisms controlling 
Brucella in the lungs. As the non Th1 immune effectors controlling 
Brucella growth in the lungs remain largely unknown, we failed to 
identify the immune effectors suppressed by IL-10 in our model.
Brucella abortus has been reported to survive and replicate 
more efficiently in arginase-1+ M2 macrophages than in iNOS+ 
M1 macrophages in vitro, notably because M2 macrophages dis-
play increased intracellular glucose availability, which promotes 
Brucella replication (52). As higher M2 alveolar macrophage 
counts have been documented during allergic asthma (51), we 
tried to determine whether asthma-induced increased Brucella 
susceptibility could be the result of the preferential invasion of M2 
macrophages by Brucella. Microscopic analysis showed a strong 
increase in the frequency of both iNOS+ and arginase-1+ cells in 
the lungs of Alt sensitized mice. However, we did not observe 
preferential co-localization of Brucella with iNOS or arginase-1 
staining in the lungs of asthmatic mice. Moreover, arginase activity 
neutralization by repeated injection of nor-NOHA did not reduce 
Brucella susceptibility induced by Alt sensitization. These results 
suggest that the positive impact of asthma on Brucella multiplica-
tion in our experimental model was not dependent on invasion 
of the M2 macrophages. However, M2 macrophages have been 
described to actively suppress the Th1 response in several likely 
redundant ways such as via the chitinase-like 3 protein (Ym1) 
(67) and programmed death ligand 2 (PD-L2) (68). We, therefore, 
cannot exclude their implication in increased susceptibility to 
Brucella infection in asthmatic mice. We also cannot exclude that 
the increased multiplication of Brucella in the macrophages of 
asthmatic mice was not partially due to the fact that these cells 
are enriched in nutrients necessary for the growth of Brucella.
The extracellular, Gram-positive bacterium S. pneumoniae is 
a serious human pathogen that causes more than 50% of cases of 
community-acquired bacterial pneumonia and is the most com-
mon cause of death from infection in developed countries [for 
a review, see Ref. (69, 70)]. In mice models, innate immunity is 
crucial during the early phase of natural anti-pneumococcal host 
defenses, and alveolar macrophages and neutrophils play a key 
role in the control of bacteria. While clinical studies have identi-
fied asthma as a significant risk factor for invasive pneumococcal 
disease (7, 71–73), we observed that our Alt sensitization protocol 
FigUre 11 | Asthma sensitization increases resistance against intranasal Streptococcus pneumoniae infection. Wild-type and CD3−/− C57BL/6 (a,B) and wild-type 
and STAT-6−/− BALB/c mice (c) were sensitized with phosphate-buffered saline (cont) or Alt before i.n. infection with a lethal CFU dose (2 × 107 CFU) of S. 
pneumonia, as indicated in the legend of each graph. (a,c) The data shown are the percentage of mice surviving infection at a given time. (B) The data represent 
the number of CFU per lung or spleen, as indicated. n indicates the number of mice per group. These results are representative of at least two independent 
experiments.
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dramatically increased the resistance of mice to S. pneumoniae 
infection, demonstrating that asthma-induced susceptibility to 
Brucella cannot be generalized to all bacterial infections in our 
experimental model and suggesting that asthma can also, in some 
cases, improve resistance to bacterial infection. Wildly conflict-
ing results have been published on the impact of asthma on S. 
pneumoniae infection in mice. Intraperitoneally, OVA-sensitized 
mice have been reported to display reduced (74), similar (75), or 
enhanced (76, 77) susceptibility to infection. The discrepancies 
between these results may be connected with the serotype of 
S. pneumoniae used, the sanitary level of the mice, or a delay 
between infection and asthma challenge. Surprisingly, in our 
model, CD3 and STAT-6 deficiency did not impair resistance to S. 
pneumoniae infection following asthma sensitization, demonstrat-
ing that this phenomenon is induced by a route that is completely 
different from that of asthma-induced Brucella susceptibility. 
Stimulation of innate lung immunity with an aerosolized lysate 
of non-typeable Haemophilus influenzae confers a high level of 
protection against a challenge with otherwise lethal inocula of 
S. pneumoniae (78). Intranasal administration of flagellin from 
Salmonella enterica serovar Typhimurium protects from S. pneu­
moniae infection in wild-type and B- and T-cell-deficient SCID 
mice, but not in neutrophil-depleted mice (33). This suggests that 
strong neutrophilia induced by asthma sensitization in STAT-6−/− 
mice (Figure S2 in Supplementary Material) could be sufficient to 
increase resistance to S. pneumoniae in our model. Interestingly, a 
recent study (79) in a mouse model reported that allergic asthma 
also decreases lung infection with Klebsiella pneumoniae in a 
neutrophil-dependent and IL-4- and IL-17-independent manner.
Finally, we also tested the impact of Alt sensitization on M. 
tuberculosis lung infection. Although the course of M. tuberculosis 
infection, like Brucella infection, is mainly controlled by IFN-γ-
producing CD4+ T cells (80–82) in mice, we observed that asthma 
sensitization does not affect M. tuberculosis multiplication in the 
lungs. It is noteworthy that while different studies indicate that 
BCG vaccination or infection with M. tuberculosis is associated 
with a decreased risk of allergic diseases (83–85) and that active 
tuberculosis disease is associated with increased allergic sensiti-
zation (86) or protection against allergy (84), no clear association 
between asthma and increased susceptibility to M. tuberculosis 
infection has been reported to the best of our knowledge. Overall, 
this result indicates again that the impact of Alt sensitization on 
Brucella infection cannot be generalized to all other intracellular 
bacterial infections.
We observed recently (87) that the strong Th1 response 
induced by Trypanosoma brucei infection significantly reduced 
FigUre 12 | Asthma sensitization does not affect the course of 
Mycobacterium tuberculosis infection in the lungs of mice. Wild-type BALB/c 
mice were sensitized with phosphate-buffered saline (cont) or Alt before 
aerosol infection with 102 CFU of M. tuberculosis. Mice were sacrificed at the 
indicated time post M. tuberculosis infection. The data show the CFU/lung. n 
indicates the number of mice per group. These results are representative of 
at least two independent experiments.
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Brucella growth but did not affect the course of M. tuberculosis 
infection in mice. Taken together, the absence of an impact of the 
Th1 response induced by T. brucei and the Th2 response induced 
by asthmatic sensitization on M. tuberculosis infection in our 
mice models is very surprising and suggests that control of M. 
tuberculosis is not simply dependent on a balance between the 
Th1 and Th2 responses.
On the whole, our results demonstrated that the same protocol 
for allergic asthma sensitization might have no effect or dramati-
cally reduce or increase resistance to bacterial infection in mice, 
depending on the infectious agent. These results open up new 
areas for investigation of immune effectors controlling Brucella 
and S. pneumoniae growth in the lungs, and suggest that it could 
be interesting to perform further clinical studies on the impact 
of asthma on Brucella and S. pneumoniae infections in humans.
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FigUre s1 | Comparison of allergic asthma models induced by intranasal 
sensitization with HDM or Alt extracts. Wild-type BALB/c mice were instilled i.n. 
with phosphate-buffered saline (control), HDM, or Alt extracts for 17 days to 
induce allergic asthma. Three days after the last sensitization, the mice were 
sacrificed and the lungs were collected to evaluate the asthma severity. (a) 
Hematoxylin and eosin (HE) staining of lung paraffin sections (scale bar: 200 µm). 
(B) Differential cell counts in bronchoalveolar lavages fluid. (c) Q-PCR analysis of 
IL-4 mRNA expression levels in the lungs. (D) Total blood IgE Ab concentration 
determined by ELISA. n denotes the number of mice used for each lineage. 
These results are representative of at least two independent experiments. 
*p < 0.05, **p < 0.01.
FigUre s2 | Impact of IL-4 and STAT6 deficiency on asthma-induced cell 
recruitment in the lungs of BALB/c mice. Wild-type, IL4−/− and STAT6−/− BALB/c 
mice received repeated i.n. administration of phosphate-buffered saline, HDM, or 
Alt before i.n. infection with 2 × 104 CFU of mCherry-Brucella melitensis. The 
mice were sacrificed at 12 days post infection to evaluate the severity of the 
allergic phenotype. (a) Circulating blood non-specific IgE Ab concentration 
determined by ELISA. (B) Number of cell counts in bronchoalveolar lavage fluid 
from control, HDM, and Alt infected mice. These results are representative of at 
least two independent experiments. **p < 0.01, ***p < 0.001.
FigUre s3 | Treatment with nor-NOHA inhibitor neutralizes arginase activity in 
lung homogenates from Alt sensitized BALB/c mice. Wild-type BALB/c mice 
received repeated i.n. administration of phosphate-buffered saline (PBS) (control) 
or Alt for 2 weeks. The mice were sacrificed and the lungs were harvested and 
homogenized. The panel represents the arginase activity/lung homogenate from 
control and Alt sensitized wild-type BALB/c mice incubated in vitro with PBS or 
nor-NONA inhibitor (2 mg/ml). These results are representative of at least two 
independent experiments. **p < 0.01, ***p < 0.001.
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